Standout Papers

Randomised study of screening for colorectal cancer with faecal-occult-blood test 1996 2026 2006 2016 1.9k
  1. Randomised study of screening for colorectal cancer with faecal-occult-blood test (1996)
    O Kronbörg, Claus Fenger et al. The Lancet

Citation Impact

Citing Papers

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
2008 Standout
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Organized Colorectal Cancer Screening in Integrated Health Care Systems
2011
Benefits and barriers to participation in colorectal cancer screening: a protocol for a systematic review and synthesis of qualitative studies
2014
Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test
2014
Decision Aid to Technologically Enhance Shared decision making (DATES): study protocol for a randomized controlled trial
2013
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
2003 Standout
Global patterns and trends in colorectal cancer incidence and mortality
2016 Standout
A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population
2003
Colorectal cancer
1999
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
1993 Standout
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Cost-Effectiveness of Colorectal Cancer Screening in Renal Transplant Recipients
2008
Market for Colorectal Cancer Screening by Endoscopy in the United States
2005
Eliminating the Need for Dietary Restrictions When Using a Sensitive Guaiac Fecal Occult Blood Test
1999
Adherence to Continuous Screening for Colorectal Neoplasia
1993
Impact of a physician-oriented intervention on follow-up in colorectal cancer screening
2004
Comparison of a brush‐sampling fecal immunochemical test for hemoglobin with a sensitive guaiac‐based fecal occult blood test in detection of colorectal neoplasia
2006
Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds
2004
A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening
2007
Sensitivity and Specificity of a Stool DNA Multitarget Assay Panel for the Detection of Advanced Colorectal Neoplasia
2003
American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer
1997
Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States
2004
Pitfalls of Converting Practice Guidelines Into Quality Measures
2004
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
1993 Standout
How much can current interventions reduce colorectal cancer mortality in the U.S.?
2006
Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population
2004
Does informed consent alter elderly patients’ preferences for colorectal cancer screening?
2000
Unmet Health Needs of Uninsured Adults in the United States
2000
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
2008 Standout
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
1996 Standout
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Early detection of pancreatic carcinoma
2002
Colon cancer screening
2000
Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics
2007
Cancer Statistics, 2009
2009 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy
2015
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
2000
Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood
1999
Cancer Statistics, 2008
2008 Standout
Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers
2003
Users' Guides to the Medical Literature
1999 Standout
Colorectal cancer mass-screening: Estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time
1997
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: Report of 100 consecutive cases
2004 Standout
Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study1☆
2004
Prospective, randomized, single-blind comparison of two preparations for screening flexible sigmoidoscopy
2000
Chemoprevention of Colorectal Cancer
2000
A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds
2002
Is There A True “Shift” To The Right Colon in The Incidence of Colorectal Cancer?
2003
Participation in Colorectal Cancer Screening: A Review
1997
Diagnostic Testing Following Fecal Occult Blood Screening in the Elderly
1999
Colorectal Neoplasms: Prospective Comparison of Thin-Section Low-Dose Multi–Detector Row CT Colonography and Conventional Colonoscopy for Detection
2002
Colorectal cancer
2013 Standout
The Use of Screening Colonoscopy for Patients Cared for by the Department of Veterans Affairs
2006
Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper
2010
Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis
2004
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Detection ofAPCMutations in Fecal DNA from Patients with Colorectal Tumors
2002
Endoscopic Colorectal Cancer Screening: a Cost-Saving Analysis
2000
Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening
2001
Screening for colorectal cancer
2005
Colorectal cancer
2019 Standout
Global cancer statistics
2011 Standout
Literacy and Knowledge, Attitudes, and Behavior About Colorectal Cancer Screening
2005
p21 in cancer: intricate networks and multiple activities
2009 Standout
Colorectal Cancer Screening: A Community Case-Control Study of Proctosigmoidoscopy, Barium Enema Radiography, and Fecal Occult Blood Test Efficacy
1999
Can Hemoccult-IITM replace colonoscopy in surveillance after radical surgery for colorectal cancer and after polypectomy?
1992
Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel
2000
Colorectal cancer screening: prospects for molecular stool analysis
2005
Patterns and predictors of colorectal cancer test use in the adult U.S. population
2004
Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update
2008
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening
2004
Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results From the Baseline Screening Examination of a Randomized Trial
2005
A Comparison of Virtual and Conventional Colonoscopy for the Detection of Colorectal Polyps
1999
The detection and management of unruptured intracranial aneurysms
2000
Cancer Statistics, 2005
2005 Standout
How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity
2004
Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test
2005
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
2013
Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
2004
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
2008
Estimates of the cancer incidence and mortality in Europe in 2006
2007 Standout
Cancer Screening in Elderly Patients
2001
Strategies for reducing maternal mortality: getting on with what works
2006 Standout
The WHO Antenatal Care Randomised Controlled Trial: rationale and study design
1998
The burden and costs of chronic diseases in low-income and middle-income countries
2007 Standout
Baseline Findings of the Italian Multicenter Randomized Controlled Trial of "Once-Only Sigmoidoscopy"--SCORE
2002
Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence
2001
The Findings and Impact of Nonrehydrated Guaiac Examination of the Rectum (FINGER) Study
1999
Electronic Patient Messages to Promote Colorectal Cancer Screening
2010
Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries
2006
Low Uptake of Colorectal Cancer Screening 3 Yr After Release of National Recommendations for Screening
2007
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding
2000
Stool screening for colorectal cancer: Molecular approaches
2005
Cancer control in women. Update 2003
2003
Variation of Agreement in Polyp Size Measurement Between Computed Tomographic Colonography and Pathology Assessment: Clinical Implications
2008
Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas)
2006
Cancer as an evolutionary and ecological process
2006 Standout
Cancer Survival Among US Whites and Minorities
2002
At what costs will screening with CT colonography be competitive? A cost‐effectiveness approach
2008
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Analysis of screening data: colorectal cancer
1997
Cancer Statistics, 2007
2007 Standout
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Pre-eclampsia
2015 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care
2001 Standout
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors
2005
A study of laboratory based faecal occult blood testing in Melbourne, Australia
1998
Burden of Gastrointestinal Disease in the United States: 2012 Update
2012 Standout
Effect of Flexible Sigmoidoscopy-Based Screening on Incidence and Mortality of Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2012
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection
2001
Genetic Progression in the Pancreatic Ducts
2000
A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult
1998
Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidence
2003 Standout
Meta-analysis of dietary restriction during fecal occult blood testing.
2001
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Health Care Provider-Directed Intervention to Increase Colorectal Cancer Screening Among Veterans: Results of a Randomized Controlled Trial
2005
Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer
2000
Harvard Report on Cancer Prevention
1999
A Comparison of the Immunochemical Fecal Occult Blood Test and Total Colonoscopy in the Asymptomatic Population
2005
Adherence to Colorectal Cancer Screening
2012
Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology
2000
Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force
2002
Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review
2020
Screening for Colorectal Cancer
2016 Standout
Possible Advantages and Drawbacks of Adding Flexible Sigmoidoscopy to Hemoccult-II in Screening for Colorectal Cancer: A Randomized Study
1999
Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report
2002
Decision aids for people facing health treatment or screening decisions
2017 Standout
Double-Contrast Barium Enema for Colorectal Cancer Screening
2000
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication
2012
The Topography of Colorectal Cancer Varies by Race/Ethnicity and Affects the Utility of Flexible Sigmoidoscopy
2001
Low Health Literacy and Health Outcomes: An Updated Systematic Review
2011 Standout
Screening for colorectal cancer using the faecal occult blood test, Hemoccult
2007
Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. In conjunction with ACG Consumer Brochure: "ACG Recommendations on Colorectal Cancer Screening for Average and Higher Risk Patients in Clinical Practice".
2000
A Prospective Multicenter Evaluation of New Fecal Occult Blood Tests in Patients Undergoing Colonoscopy
2000
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies
2016
The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer
2012
Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality
2014
Population-Based Surveillance by Colonoscopy: Effect on the Incidence of Colorectal Cancer: Telemark Polyp Study I
1999
A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood
2005
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Patterns of Colorectal Cancer Test Use, Including CT Colonography, in the 2010 National Health Interview Survey
2012
A Randomised Trial of the Impact of New Faecal Haemoglobin Test Technologies on Population Participation in Screening for Colorectal Cancer
2003
Global cancer statistics, 2012
2015 Standout
Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice
2005
The Impact of Nearly Universal Insurance Coverage on Health Care Utilization: Evidence from Medicare
2008 StandoutNobel
Attitudes toward colorectal cancer screening tests
2001
The Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study
2003
A randomized questionnaire based study on the impact of providing numerical information on colorectal cancer screening
2011
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial
2002
Colorectal Cancer Prevention
2005
Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program
2015
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study
2004 Standout
Enhanced Retrieval of DNA from Human Fecal Samples Results in Improved Performance of Colorectal Cancer Screening Test
2004
Colorectal Cancer Test Use from the 2005 National Health Interview Survey
2008
Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
2001
Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force
2008
Secular Trends in Colon and Rectal Cancer Relative Survival
2013
ACG Clinical Guidelines: Colorectal Cancer Screening 2021
2021

Works of Ole Søndergaard being referenced

Repeated Screening for Colorectal Cancer with Fecal Occult Blood Test: A Prospective Randomized Study at Funen, Denmark
1989
Randomised study of screening for colorectal cancer with faecal-occult-blood test
1996 Standout
Participation in Mass Screening for Colorectal Cancer with Fecal Occult Blood Test
1986
Rankless by CCL
2026